Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction

Danish Ali, Patrick Tran, Stuart Ennis, Richard Powell, Scott McGuire, Gordon McGregor, Peter K. Kimani, Martin O. Weickert, Michelle A. Miller, Francesco P. Cappuccio, Prithwish Banerjee

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Aims: Comorbidities play a significant role towards the pathophysiology of heart failure with preserved ejection fraction (HFpEF), characterized by abnormal macrovascular function and altered ventricular–vascular coupling. However, our understanding of the role of comorbidities and arterial stiffness in HFpEF remains incomplete. We hypothesized that HFpEF is preceded by a cumulative rise in arterial stiffness as cardiovascular comorbidities accumulate, beyond that associated with ageing. Methods and results: Arterial stiffness was assessed using pulse wave velocity (PWV) in five groups: Group A, healthy volunteers (n = 21); Group B, patients with hypertension (n = 21); Group C, hypertension and diabetes mellitus (n = 20); Group D, HFpEF (n = 21); and Group E, HF with reduced ejection fraction (HFrEF) (n = 11). All patients were aged 70 and above. Mean PWV increased from Groups A to D (PWV 10.2, 12.2, 13.0, and 13.7 m/s, respectively) as vascular comorbidities accumulated independent of age, renal function, haemoglobin, obesity (body mass index), smoking status, and hypercholesterolaemia. HFpEF exhibited the highest PWV and HFrEF displayed near-normal levels (13.7 vs. 10 m/s, P = 0.003). PWV was inversely related to peak oxygen consumption (r = −0.304, P = 0.03) and positively correlated with left ventricular filling pressures (E/e′) on echocardiography (r = −0.307, P = 0.014). Conclusions: This study adds further support to the concept of HFpEF as a disease of the vasculature, underlined by an increasing arterial stiffness that is driven by vascular ageing and accumulating vascular comorbidities, for example, hypertension and diabetes. Reflecting a pulsatile arterial afterload associated with diastolic dysfunction and exercise capacity, PWV may provide a clinically relevant tool to identify at-risk intermediate phenotypes (e.g. pre-HFpEF) before overt HFpEF occurs.

Original languageEnglish
Pages (from-to)2487-2498
Number of pages12
JournalESC heart failure
Issue number4
Publication statusPublished - Aug 2023
Externally publishedYes


  • Arterial stiffness
  • Heart failure with preserved ejection fraction
  • Pulse wave velocity
  • Ventricular–arterial coupling


Dive into the research topics of 'Rising arterial stiffness with accumulating comorbidities associates with heart failure with preserved ejection fraction'. Together they form a unique fingerprint.

Cite this